rxstat › Classes › Adrenergics, Inhalants
Adrenergics, Inhalants: shortage status in Canada
2 of the 7 adrenergics, inhalants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Salbutamol (Ventolin Nebules P.f. -) Partial shortage 6 of 23 reported products affected
Salbutamol Ipratropium Bromide (Combivent Udv) Partial shortage 1 of 6 reported products affected
Salmeterol Fluticasone Propionate (Advair) Shortage anticipated 0 of 7 reported products affected
Formoterol (Foradil Dry) Discontinued 0 of 1 reported products affected
Indacaterol (Onbrez Breezhaler) Discontinued 0 of 1 reported products affected
Mometasone Furoate Formoterol (Zenhale) Discontinued 0 of 2 reported products affected
Salmeterol (Serevent Diskus) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.